Hanmi, emerging as strong competitor in domestic generic market

Hanmi Pharm is expected to grab bigger pie in the nation’s generic market where many players are rushing to introduce first generic versions of off-patent drugs, according to a local analyst.

Kim Tae-hee, an analyst of Dongbu Securities, said that Hanmi has lead the first generic version launch of drugs thus far.

Back by its strong sales force and R&D capability, Hanmi has strengthened i...